PPA
TBIO

Parametric Portfolio Associates’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Parametric Portfolio Associates’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$63K Sell
650
-1,161
-64% -$176K ﹤0.01% 3611
2021
Q4 		$352K Buy
+1,811
New +$282K ﹤0.01% 3221

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parametric Portfolio Associates's TBIO Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Telesis Bio, Inc. Common Stock (TBIO) stake by 64% in Q1 2022, selling an estimated $176K and leaving 650 shares worth $63K. The position accounts for ﹤0.01% of the portfolio, ranked #3611.

Parametric Portfolio Associates first reported a position in TBIO in Q4 2021 and has held it in 2 quarters since. The position peaked at $352K in Q4 2021. 47 funds tracked by Wall St. Rank hold TBIO as of Q1 2022.

  • Parametric Portfolio Associates held 650 shares of Telesis Bio, Inc. Common Stock worth $63K as of Q1 2022.
  • Parametric Portfolio Associates sold 1,161 Telesis Bio, Inc. Common Stock shares in Q1 2022, an estimated $176K.
  • Telesis Bio, Inc. Common Stock made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3611 holding.
  • Parametric Portfolio Associates first reported a position in Telesis Bio, Inc. Common Stock in Q4 2021 and has held it in 2 quarters since.
  • Parametric Portfolio Associates's Telesis Bio, Inc. Common Stock position peaked at $352K in Q4 2021.
  • 47 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.